A genetic identity card for Plasmodium populations to improve control strategiesNovember 09, 2007WHO figures show that malaria currently affects between 300 and 600 million people in various parts of the world. Several malaria-hit regions are experiencing an advance of the disease owing to the parasite's increasing resistance to most antimalarial drugs. Any increase in efficacy of medical treatments, with optimal limitation of resistance, requires that scientists unravel the evolutionary strategies of the enemy they are fighting. One of the research leads involves prior determination of the population genetic structure of Plasmodium falciparum. This work was recently accomplished by a joint team of researchers from the IRD and the CNRS (2). Dissections were conducted on over 10 000 mosquitoes of the species Anopheles gambiae and Anopheles funestus, two of the principal malaria vectors in Sub-Saharan Africa. The work was done simultaneously on two sites in Cameroon and one Kenyan site, all three strongly infected by malaria. This large-scale investigation resulted in the isolation of 746 Plasmodium falciparum oocysts from the gut of 183 infected mosquitoes. Two years previously, a preliminary study carried out in Kenya by the same team solely on A. gambiae, had yielded 600 oocysts from 145 infected mosquitoes caught in 11 different localities. The oocyst of the parasite provided the researchers with a means of access to the diploid phase of the microorganism, containing all its genetic information. Up to then, nearly all studies aiming to determine the genetic structure of Plasmodium populations were elaborated with parasite samples taken from humans. However, that kind of genetic analysis results in several points of bias. With samples collected from humans, scientists can work only on the haploid phase of the parasite cycle during which only one example of each chromosome is present. Therefore they cannot measure the rate of association and organization between genes within populations. Moreover, in the zones where malaria is endemic, infected individuals are bitten regularly by mosquito vectors. Consequently, there is a high frequency of infection of one subject by several Plasmodium falciparum with different genotypes. Monoinfected patients, the only ones that can be selected for a pertinent genetic analysis, are therefore too rare to enable scientists to obtain representative results. Assays on short sequences of DNA located on the 14 chromosome pairs of the parasite genome enabled the IRD and CNRS team to draw up quite a detailed genetic identity card of the different populations studied. They revealed an extremely high rate of genetic diversity but also a considerable overall rate of inbreeding, approaching 50%. This high level of inbreeding can be explained by the existence of a process of self-fertilization, selfing (3), combined with a non-random genotypic distribution of parasite oocysts in the mosquito vector guts. The set of data corroborated those acquired in Kenya in 2005. They confirmed the persistence of a strong population genetic structure of Plasmodium between mosquito vectors, associated with a reproduction regime combining genetic mixing and selfing. A genetic identity card of Plasmodium falciparum populations could help improve malaria control strategies. The use of mathematical models that take into account genetic information about parasite infection foci could then feasibly predict the changes occurring in genes involved in drug resistance. Therapies could then be targeted according to the evolution dynamics of Plasmodium populations with the aim of controlling parasite populations while minimizing resistance development. This study also proved that the parasite's overall reproduction strategy is the same in the two vector species investigated. One of the approaches envisaged by the international scientific community for limiting morbidity from malaria would entail the progressive eradication of its principal vector Anopheles gambiae. To achieve this some research teams envisage the introduction into the wild of mosquitoes modified genetically to render them incapable of transmitting the parasite to humans. However, seeing that Plasmodium can use a number of different vectors, neutralizing just one, albeit one of the most dangerous, runs the risk of weakening only slightly the efficiency of the parasite's reproduction strategy which could then merely switch to the other available vectors. (1) Plasmodium's life-cycle is set off as soon as a female Anopheles mosquito containing a form of the parasite called the sporozoite in its salivary glands bites a human. Once in the blood circulation, some of these parasites can develop into a sexually predetermined form: the male and female gametocytes. The mosquito ingests these gametocytes when it takes a second blood meal. They then migrate into its digestive tube where they give rise to male and female gametes. A process of fertilization ensues which produces the oocyst. (2) This research programme was conducted with the aid of the Kenya Medical Research Institute, the 'Organisation de control contre les endémies en Africa Centrale', the French Ministry of Higher Education and Research and the Institute of evolution and the University of California. (3) Self-fertilization, or selfing, results from the fusion of a female gamete and a male gamete originating from one and the same parasite genotype and therefore from the same individual. Institut de Recherche Pour le Développement |
|||||||||||||||||||||
| Related Plasmodium Current Events and Plasmodium News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Media availability: The role of biomedical research in malaria eradication Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year. UM School of Medicine researchers find extreme genetic variability in malaria parasite Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. UCI researchers create new strategy for highly-selective chemotherapy delivery UC Irvine researchers have created a new approach that vastly improves the targeting of chemotherapeutic drugs to specific cells and organs. New research confirms potential deadly nature of emerging new monkey malaria species in humans Researchers in Malaysia have identified key laboratory and clinical features of an emerging new form of malaria infection. Scientists report original source of malaria Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa. Unique immunization method provides insights about protective anti-malaria immune response In this week's New England Journal of Medicine, scientists in Singapore, The Netherlands and France report that they have developed a novel immunization method that will induce fast and effective protection in humans against the life-threatening malaria parasite, Plasmodium falciparum, which infects 350 to 500 million people world-wide and kills over one million people each year. First genetically-engineered malaria vaccine to enter human trials Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. Case Western Reserve researchers discover the key to malaria susceptibility in children A team of researchers from Case Western Reserve University School of Medicine have solved the mystery of why some children are more susceptible to malaria infection and anemia. More Plasmodium Current Events and Plasmodium News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||